The complement system in neurodegenerative diseases
Jacqui Nimmo(UK Dementia Research Institute), B. Paul Morgan(UK Dementia Research Institute), Lewis M. Watkins(UK Dementia Research Institute), Wioleta M. Zelek(UK Dementia Research Institute), Nikoleta Daskoulidou(UK Dementia Research Institute), Sarah M. Carpanini(UK Dementia Research Institute), Robert A.J. Byrne(UK Dementia Research Institute)
Cited by 48
Related Papers
Inflammatory biomarkers in Alzheimer's disease plasma
|Alzheimer s & Dementia|2019|207
Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis
|Journal of Clinical Investigation|2011|129
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
|Acta Neuropathologica Communications|2022|97
Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
|Alzheimer s Research & Therapy|2020|48
The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy
|International Journal of Molecular Sciences|2020|47